biote Corp.
corporate_fare Company Profile
biote Corp. (NASDAQ:BTMD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 15 items for BTMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 8/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for BTMD spans 10-Q, 4, 8-K, 8-K/A.
Recent high-impact activity:
- Biote 10-Q: Covenant Breach Waived, Cash Falls to $8.9M, Material Weakness Persists
- Q3 Revenue Falls 9.6% as Biote's Turnaround Stalls; Guidance Held
- Executive Chairman Marc Beer Buys $202K of Biote Stock
- Biote Q2 Loss Deepens, Material Weakness Lingers, and CEO Transition Concludes
- Biote Swings to Q2 Loss, Slashes Full-Year Outlook as Recall Fallout Persists
Financial Snapshot
Short Interest & Short Volume
10.21 days to coverFINRA reported short interest of 841,390 shares in BTMD as of the October 30, 2026 settlement, a 28.8% decrease from the prior period — about 10.2 days to cover at its recent average daily volume. On November 20, 2026, 36.3% of BTMD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.